Heart Rate Variability as an Alternative Indicator for Identifying Cardiac Iron Status in Non-Transfusion Dependent Thalassemia Patients

被引:18
|
作者
Wijarnpreecha, Karn [1 ,2 ,3 ]
Siri-Angkul, Natthaphat [1 ,2 ,3 ]
Shinlapawittayatorn, Krekwit [1 ,2 ,3 ]
Charoenkwan, Pimlak [3 ,4 ]
Silvilairat, Suchaya [3 ,4 ]
Siwasomboon, Chate [5 ]
Visarutratna, Pannee [5 ]
Srichairatanakool, Somdet [6 ]
Tantiworawit, Adisak [7 ]
Phrommintikul, Arintaya [7 ]
Chattipakorn, Siriporn C. [1 ,3 ,8 ]
Chattipakorn, Nipon [1 ,2 ,3 ]
机构
[1] Chiang Mai Univ, Fac Med, Cardiac Electrophysiol Res & Training Ctr, Chiang Mai 50000, Thailand
[2] Chiang Mai Univ, Fac Med, Dept Physiol, Cardiac Electrophysiol Unit, Chiang Mai 50000, Thailand
[3] Chiang Mai Univ, Ctr Excellence Cardiac Elect, Chiang Mai 50000, Thailand
[4] Chiang Mai Univ, Fac Med, Dept Pediat, Chiang Mai 50000, Thailand
[5] Chiang Mai Univ, Fac Med, Dept Radiol, Chiang Mai 50000, Thailand
[6] Chiang Mai Univ, Fac Med, Dept Biochem, Chiang Mai 50000, Thailand
[7] Chiang Mai Univ, Fac Med, Dept Internal Med, Chiang Mai 50000, Thailand
[8] Chiang Mai Univ, Fac Med, Dept Oral Biol & Diagnost Sci, Chiang Mai 50000, Thailand
来源
PLOS ONE | 2015年 / 10卷 / 06期
关键词
TRANSFERRIN-BOUND IRON; LABILE PLASMA IRON; OXIDATIVE STRESS; OVERLOAD CARDIOMYOPATHY; MAGNETIC-RESONANCE; CHELATION-THERAPY; SERUM FERRITIN; RISK; PATHOPHYSIOLOGY; METABOLISM;
D O I
10.1371/journal.pone.0130837
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Iron-overload cardiomyopathy is a major cause of death in thalassemia patients due to the lack of an early detection strategy. Although cardiac magnetic resonance (CMR) T2* is used for early detection of cardiac iron accumulation, its availability is limited. Heart rate variability (HRV) has been used to evaluate cardiac autonomic function and found to be depressed in thalassemia. However, its direct correlation with cardiac iron accumulation has never been investigated. We investigated whether HRV can be used as an alternative indicator for early identification of cardiac iron deposition in thalassemia patients. Methods Ninety-nine non-transfusion dependent thalassemia patients (23.00 (17.00, 32.75) years, 35 male) were enrolled. The correlation between HRV recorded using 24-hour Holter monitoring and non-transferrin bound iron (NTBI), hemoglobin (Hb), serum ferritin, LV ejection fraction (LVEF), and CMR-T2* were determined. Results The median NTBI value was 3.15 (1.11, 6.59) mu M. Both time and frequency domains of HRV showed a significant correlation with the NTBI level, supporting HRV as a marker of iron overload. Moreover, the LF/HF ratio showed a significant correlation with CMR-T2* with the receiver operating characteristic (ROC) curve of 0.684 +/- 0.063, suggesting that it could represent the cardiac iron deposit in thalassemia patients. HRV was also significantly correlated with serum ferritin and Hb. Conclusions This novel finding regarding the correlation between HRV and CMR-T2* indicates that HRV could be a potential marker in identifying early cardiac iron deposition prior to the development of LV dysfunction, and may be used as an alternative to CMR-T2* for screening cardiac iron status in thalassemia patients.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] IRON CHELATION IN PATIENTS WITH THALASSEMIA INTERMEDIA AND OTHER NON TRANSFUSION DEPENDENT CONGENITAL HEMOLYTIC ANEMIAS
    Pereira, A. Alves
    Silveira, M. P.
    Ribeiro, M. L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 512 - 512
  • [32] Evaluation of Erythroferrone, Hepcidin, and Iron Overload Status in Iraqi Transfusion-Dependent β-Thalassemia Major Patients
    Smesam, Hasan N. K.
    Albuthabhak, Hasan A. Q.
    Arjmand, Sareh
    Al-Hakeim, Hussein K.
    Siadat, Seyed Omid R.
    HEMOGLOBIN, 2020, 44 (04) : 272 - 277
  • [33] Correlation of Serum Ferritin and Cardiac Iron Toxicity with Cardiac Function in Transfusion Dependent Beta-Thalassemia Major Patients
    Atmakusuma, Tubagus Djumhana
    Kalwani, Rajesh
    Nasution, Sally Aman
    Rumende, Cleopas Martin
    ACTA MEDICA INDONESIANA, 2021, 53 (03) : 291 - 298
  • [34] Phase 2 Clinical Trial Results for Bitopertin, an Oral Glycine Transporter 1 Inhibitor, in Patients with Non-Transfusion Dependent Beta-Thalassemia
    Taher, Ali
    Viprakasit, Vip
    Cappellini, Maria Domenica
    Kraus, Dominik
    Cech, Patrick
    Dietmar, Volz
    Winter, Erica
    Mazer, Norman Alan
    Nave, Stephane
    Dukart, Juergen
    Stark, Franziska Schaedeli
    Koerner, Annette
    Khwaja, Omar
    Hermosilla, Ricardo
    BLOOD, 2018, 132
  • [35] A double-blind, controlled, crossover trial of amlodipine on iron overload status in transfusion dependent β-thalassemia patients
    Karami, Hossein
    Arjmandi, Hadiseh Khalilzadeh
    Salehifar, Ebrahim
    Darvishi-Khezri, Hadi
    Dabirian, Mojdeh
    Kosaryan, Mehrnoush
    Aliasgharian, Aily
    Akbarzadeh, Rosetta
    Aali, Raheleh Naeimayi
    Nasirzadeh, Amirreza
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (08)
  • [36] Correlation of NT-proBNP levels and cardiac iron concentration in patients with transfusion-dependent thalassemia major
    Delaporta, Polyxeni
    Kattamis, Antonios
    Apostolakou, Filia
    Boiu, Sorina
    Bartzeliotou, Anastasia
    Tsoukas, Evangelos
    Papassotiriou, Ioannis
    BLOOD CELLS MOLECULES AND DISEASES, 2013, 50 (01) : 20 - 24
  • [37] Correlation of NT-ProBNP Levels and Cardiac Iron Concentration in Patients with Transfusion-Dependent Thalassemia Major
    Kattamis, Antonios
    Apostolakou, Filia
    Delaporta, Polyxeni
    Papassotiriou, Ioannis
    BLOOD, 2011, 118 (21) : 1378 - 1379
  • [38] A Closer Look at Changes in Hemoglobin Levels in Patients with Non-Transfusion Dependent ß-Thalassemia Treated with Luspatercept: Post Hoc Analysis of the Phase 2 BEYOND Trial
    Musallam, Khaled M.
    Taher, Ali T.
    Porter, John B.
    Kattamis, Antonis
    Glassberg, Mrudula B.
    Bueno, Luciana
    Shetty, Jeevan K.
    Lersch, Frederik
    Rosettani, Barbara
    Cappellini, Maria Domenica Domenica
    BLOOD, 2022, 140 : 5358 - 5359
  • [39] THE IMPACT OF CARDIAC AND HEPATIC MRI ASSESSMENT ON THE CLINICAL MANAGEMENT OF AUSTRALIAN PATIENTS WITH TRANSFUSION DEPENDENT ANEMIAS OR NON-TRANSFUSION-DEPENDENT THALASSEMIA IN THE TIMES STUDY
    Ho, P. J.
    Hiwase, D.
    Ramakrishna, R.
    Viiala, N.
    Ross, D.
    Zor, E.
    Gervasio, O.
    Bowden, D. K.
    HAEMATOLOGICA, 2016, 101 : 616 - 617
  • [40] Impact of genotype on multi-organ iron and complications in patients with non-transfusion-dependent β-thalassemia intermedia
    Antonella Meloni
    Laura Pistoia
    Paolo Ricchi
    Sergio Bagnato
    Filomena Longo
    Giuseppe Messina
    Sabrina Bagnato
    Vincenza Rossi
    Stefania Renne
    Riccardo Righi
    Priscilla Fina
    Vincenzo Positano
    Filippo Cademartiri
    Annals of Hematology, 2024, 103 : 1887 - 1896